Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Loss of expression of μ-protocadherin and protocadherin-24 in sporadic and hereditary non polyposis colorectal cancers (HNPCC).

Losi L, Lancellotti C, Parenti S, BSc LS, Zanocco-Marani T, Buffoli F, Grassia R, Ferrari S, Grande A.

Hum Pathol. 2018 Oct 5. pii: S0046-8177(18)30383-6. doi: 10.1016/j.humpath.2018.09.019. [Epub ahead of print]

PMID:
30296522
2.

KLF4 Mediates the Effect of 5-ASA on the β-Catenin Pathway in Colon Cancer Cells.

Parenti S, Montorsi L, Fantini S, Mammoli F, Gemelli C, Atene CG, Losi L, Frassineti C, Calabretta B, Tagliafico E, Ferrari S, Zanocco-Marani T, Grande A.

Cancer Prev Res (Phila). 2018 Aug;11(8):503-510. doi: 10.1158/1940-6207.CAPR-17-0382. Epub 2018 May 24.

PMID:
29794245
3.

Loss of ZFP36 expression in colorectal cancer correlates to wnt/ ß-catenin activity and enhances epithelial-to-mesenchymal transition through upregulation of ZEB1, SOX9 and MACC1.

Montorsi L, Guizzetti F, Alecci C, Caporali A, Martello A, Atene CG, Parenti S, Pizzini S, Zanovello P, Bortoluzzi S, Ferrari S, Grande A, Zanocco-Marani T.

Oncotarget. 2016 Sep 13;7(37):59144-59157. doi: 10.18632/oncotarget.10828.

4.

Expression of μ-protocadherin is negatively regulated by the activation of the β-catenin signaling pathway in normal and cancer colorectal enterocytes.

Montorsi L, Parenti S, Losi L, Ferrarini F, Gemelli C, Rossi A, Manco G, Ferrari S, Calabretta B, Tagliafico E, Zanocco-Marani T, Grande A.

Cell Death Dis. 2016 Jun 16;7:e2263. doi: 10.1038/cddis.2016.163.

5.

ZFP36 stabilizes RIP1 via degradation of XIAP and cIAP2 thereby promoting ripoptosome assembly.

Selmi T, Alecci C, dell' Aquila M, Montorsi L, Martello A, Guizzetti F, Volpi N, Parenti S, Ferrari S, Salomoni P, Grande A, Zanocco-Marani T.

BMC Cancer. 2015 May 6;15:357. doi: 10.1186/s12885-015-1388-5.

6.

MafB is a downstream target of the IL-10/STAT3 signaling pathway, involved in the regulation of macrophage de-activation.

Gemelli C, Zanocco Marani T, Bicciato S, Mazza EM, Boraschi D, Salsi V, Zappavigna V, Parenti S, Selmi T, Tagliafico E, Ferrari S, Grande A.

Biochim Biophys Acta. 2014 May;1843(5):955-64. doi: 10.1016/j.bbamcr.2014.01.021. Epub 2014 Jan 25.

7.

The Orosomucoid 1 protein is involved in the vitamin D - mediated macrophage de-activation process.

Gemelli C, Martello A, Montanari M, Zanocco Marani T, Salsi V, Zappavigna V, Parenti S, Vignudelli T, Selmi T, Ferrari S, Grande A.

Exp Cell Res. 2013 Dec 10;319(20):3201-13. doi: 10.1016/j.yexcr.2013.08.017. Epub 2013 Aug 22.

PMID:
23973664
8.

ZFP36 expression impairs glioblastoma cell lines viability and invasiveness by targeting multiple signal transduction pathways.

Selmi T, Martello A, Vignudelli T, Ferrari E, Grande A, Gemelli C, Salomoni P, Ferrari S, Zanocco-Marani T.

Cell Cycle. 2012 May 15;11(10):1977-87. doi: 10.4161/cc.20309. Epub 2012 May 15.

PMID:
22544323
9.

TIS11/TTP gene family: it's never too late for tumor suppressors .

Zanocco-Marani T.

Cell Cycle. 2010 Dec 15;9(24):4771. Epub 2010 Dec 15. No abstract available.

PMID:
21150321
10.

ZFP36L1 negatively regulates erythroid differentiation of CD34+ hematopoietic stem cells by interfering with the Stat5b pathway.

Vignudelli T, Selmi T, Martello A, Parenti S, Grande A, Gemelli C, Zanocco-Marani T, Ferrari S.

Mol Biol Cell. 2010 Oct 1;21(19):3340-51. doi: 10.1091/mbc.E10-01-0040. Epub 2010 Aug 11.

11.

TFE3 transcription factor regulates the expression of MAFB during macrophage differentiation.

Zanocco-Marani T, Vignudelli T, Parenti S, Gemelli C, Condorelli F, Martello A, Selmi T, Grande A, Ferrari S.

Exp Cell Res. 2009 Jul 1;315(11):1798-808. doi: 10.1016/j.yexcr.2009.03.018. Epub 2009 Mar 28.

PMID:
19332055
12.

The vitamin D3/Hox-A10 pathway supports MafB function during the monocyte differentiation of human CD34+ hemopoietic progenitors.

Gemelli C, Orlandi C, Zanocco Marani T, Martello A, Vignudelli T, Ferrari F, Montanari M, Parenti S, Testa A, Grande A, Ferrari S.

J Immunol. 2008 Oct 15;181(8):5660-72.

13.

Tfe3 expression is closely associated to macrophage terminal differentiation of human hematopoietic myeloid precursors.

Zanocco-Marani T, Vignudelli T, Gemelli C, Pirondi S, Testa A, Montanari M, Parenti S, Tenedini E, Grande A, Ferrari S.

Exp Cell Res. 2006 Dec 10;312(20):4079-89. Epub 2006 Sep 22.

PMID:
17046750
14.

Identification of a molecular signature predictive of sensitivity to differentiation induction in acute myeloid leukemia.

Tagliafico E, Tenedini E, Manfredini R, Grande A, Ferrari F, Roncaglia E, Bicciato S, Zini R, Salati S, Bianchi E, Gemelli C, Montanari M, Vignudelli T, Zanocco-Marani T, Parenti S, Paolucci P, Martinelli G, Piccaluga PP, Baccarani M, Specchia G, Torelli U, Ferrari S.

Leukemia. 2006 Oct;20(10):1751-8. Epub 2006 Aug 17.

PMID:
16932344
15.

Virally mediated MafB transduction induces the monocyte commitment of human CD34+ hematopoietic stem/progenitor cells.

Gemelli C, Montanari M, Tenedini E, Zanocco Marani T, Vignudelli T, Siena M, Zini R, Salati S, Tagliafico E, Manfredini R, Grande A, Ferrari S.

Cell Death Differ. 2006 Oct;13(10):1686-96. Epub 2006 Feb 3.

16.

Correlation between differentiation plasticity and mRNA expression profiling of CD34+-derived CD14- and CD14+ human normal myeloid precursors.

Montanari M, Gemelli C, Tenedini E, Zanocco Marani T, Vignudelli T, Siena M, Zini R, Salati S, Chiossi G, Tagliafico E, Manfredini R, Grande A, Ferrari S.

Cell Death Differ. 2005 Dec;12(12):1588-600. Epub 2005 Jun 10.

17.

The kinetic status of hematopoietic stem cell subpopulations underlies a differential expression of genes involved in self-renewal, commitment, and engraftment.

Manfredini R, Zini R, Salati S, Siena M, Tenedini E, Tagliafico E, Montanari M, Zanocco-Marani T, Gemelli C, Vignudelli T, Grande A, Fogli M, Rossi L, Fagioli ME, Catani L, Lemoli RM, Ferrari S.

Stem Cells. 2005 Apr;23(4):496-506.

18.

Development of an IL-6 antagonist peptide that induces apoptosis in 7TD1 cells.

Manfredini R, Tenedini E, Siena M, Tagliafico E, Montanari M, Grande A, Zanocco-Marani T, Poligani C, Zini R, Gemelli C, Bergamaschi A, Vignudelli T, De Rienzo F, De Benedetti PG, Menziani MC, Ferrari S.

Peptides. 2003 Aug;24(8):1207-20.

PMID:
14612193
19.

Italian family with two independent mutations: 3358T/A in BRCA1 and 8756delA in BRCA2 genes.

Cortesi L, Turchetti D, Bertoni C, Zanocco-Marani T, Vinceti M, Silvestri C, Federico M, Silingardi V, Ferrari S.

Eur J Hum Genet. 2003 Mar;11(3):210-4.

20.

Requirement of the coiled-coil domains of p92(c-Fes) for nuclear localization in myeloid cells upon induction of differentiation.

Tagliafico E, Siena M, Zanocco-Marani T, Manfredini R, Tenedini E, Montanari M, Grande A, Ferrari S.

Oncogene. 2003 Mar 20;22(11):1712-23.

PMID:
12642874
21.

Gene expression profile of Vitamin D3 treated HL60 cells shows an incomplete molecular phenotypic conversion to monocytes.

Tagliafico E, Tenedini E, Bergamaschi A, Manfredini R, Percudani R, Siena M, Zanocco-Marani T, Grande A, Montanari M, Gemelli C, Torelli U, Ferrari S.

Cell Death Differ. 2002 Nov;9(11):1185-95.

22.

Physiological levels of 1alpha, 25 dihydroxyvitamin D3 induce the monocytic commitment of CD34+ hematopoietic progenitors.

Grande A, Montanari M, Tagliafico E, Manfredini R, Zanocco Marani T, Siena M, Tenedini E, Gallinelli A, Ferrari S.

J Leukoc Biol. 2002 Apr;71(4):641-51.

PMID:
11927651
23.

Efficient in vitro and in vivo gene regulation of a retrovirally delivered pro-apoptotic factor under the control of the Drosophila HSP70 promoter.

Romano G, Reiss K, Tu X, Peruzzi F, Belletti B, Wang JY, Zanocco-Marani T, Baserga R.

Gene Ther. 2001 Apr;8(8):600-7.

24.

A functionally active RARalpha nuclear receptor is expressed in retinoic acid non responsive early myeloblastic cell lines.

Grande A, Montanari M, Manfredini R, Tagliafico E, Zanocco-Marani T, Trevisan F, Ligabue G, Siena M, Ferrari S, Ferrari S.

Cell Death Differ. 2001 Jan;8(1):70-82.

25.

Insulin receptor substrate-1, p70S6K, and cell size in transformation and differentiation of hemopoietic cells.

Valentinis B, Navarro M, Zanocco-Marani T, Edmonds P, McCormick J, Morrione A, Sacchi A, Romano G, Reiss K, Baserga R.

J Biol Chem. 2000 Aug 18;275(33):25451-9.

26.

Biological activities and signaling pathways of the granulin/epithelin precursor.

Zanocco-Marani T, Bateman A, Romano G, Valentinis B, He ZH, Baserga R.

Cancer Res. 1999 Oct 15;59(20):5331-40.

27.

Dissociation between resistance to apoptosis and the transformed phenotype in IGF-I receptor signaling.

Romano G, Prisco M, Zanocco-Marani T, Peruzzi F, Valentinis B, Baserga R.

J Cell Biochem. 1999 Feb 1;72(2):294-310.

PMID:
10022512
28.

The granulin/epithelin precursor abrogates the requirement for the insulin-like growth factor 1 receptor for growth in vitro.

Xu SQ, Tang D, Chamberlain S, Pronk G, Masiarz FR, Kaur S, Prisco M, Zanocco-Marani T, Baserga R.

J Biol Chem. 1998 Aug 7;273(32):20078-83. Erratum in: J Biol Chem 1998 Dec 18;273(51):34661.

Supplemental Content

Loading ...
Support Center